Clearpoint Neuro Inc
NASDAQ:CLPT
Clearpoint Neuro Inc
Revenue
Clearpoint Neuro Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
Revenue
$31.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
23%
|
CAGR 10-Years
24%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$17.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$22.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$42.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$8.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Clearpoint Neuro Inc
Revenue Breakdown
Breakdown by Geography
Clearpoint Neuro Inc
Breakdown by Segments
Clearpoint Neuro Inc
|
Total Revenue:
31.4m
USD
|
|
Biologics And Drug Delivery:
17.3m
USD
|
|
Neurosurgery Navigation And Therapy:
10.3m
USD
|
|
Capital Equipment And Software:
3.8m
USD
|
Clearpoint Neuro Inc
Glance View
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.
See Also
What is Clearpoint Neuro Inc's Revenue?
Revenue
31.4m
USD
Based on the financial report for Dec 31, 2024, Clearpoint Neuro Inc's Revenue amounts to 31.4m USD.
What is Clearpoint Neuro Inc's Revenue growth rate?
Revenue CAGR 10Y
24%
Over the last year, the Revenue growth was 31%. The average annual Revenue growth rates for Clearpoint Neuro Inc have been 24% over the past three years , 23% over the past five years , and 24% over the past ten years .
You don't have any saved screeners yet